Lorbrena (lorlatinib) - Pfizer
Long-term safety of lorlatinib after 7 years in CROWN: kinetics, management, and correlations with efficacy (JADPRO 2026) - Oct 16, 2026 - Abstract #JL1419ES; Pres time: Oct 17, 2026; 11:00 AM - 12:00 PM; Location: Exhibit Hall C; No abstract available 
Clinical
https://jadpro.broadcastmed.io/live/77/page/553?poster_id=1725
 
Geoffrey Liu1; Benjamin J. Solomon2; Alice T. Shaw3; Julien Mazieres4; Dong-Wan Kim5; Diego Cortinovis,67; Takako Inoue8; Richu Sharma9; Nada Rifi10; Anna Polli11; Tony S. K. Mok12
 
Oct 16, 2026
 
Prev Next